BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18478569)

  • 1. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis.
    Salim EI; Morimura K; Menesi A; El-Lity M; Fukushima S; Wanibuchi H
    Int J Cancer; 2008 Aug; 123(3):601-8. PubMed ID: 18478569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.
    Warren W; Biggs PJ; el-Baz M; Ghoneim MA; Stratton MR; Venitt S
    Carcinogenesis; 1995 May; 16(5):1181-9. PubMed ID: 7767983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrative DNA damage and Oct3/4 expression in urinary bladder cancer with Schistosoma haematobium infection.
    Ma N; Thanan R; Kobayashi H; Hammam O; Wishahi M; El Leithy T; Hiraku Y; Amro el-K; Oikawa S; Ohnishi S; Murata M; Kawanishi S
    Biochem Biophys Res Commun; 2011 Oct; 414(2):344-9. PubMed ID: 21951846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide synthase immunoreactivity in human bladder carcinoma.
    Shochina M; Fellig Y; Sughayer M; Pizov G; Vitner K; Podeh D; Hochberg A; Ariel I
    Mol Pathol; 2001 Aug; 54(4):248-52. PubMed ID: 11477140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor markers of bladder cancer: the schistosomal bladder tumors versus non-schistosomal bladder tumors.
    Abdulamir AS; Hafidh RR; Kadhim HS; Abubakar F
    J Exp Clin Cancer Res; 2009 Feb; 28(1):27. PubMed ID: 19243595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage repair in bladder urothelium after the Chernobyl accident in Ukraine.
    Romanenko A; Morimura K; Wei M; Zaparin W; Vozianov A; Fukushima S
    J Urol; 2002 Sep; 168(3):973-7. PubMed ID: 12187202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased oxidative stress with gene alteration in urinary bladder urothelium after the Chernobyl accident.
    Romanenko A; Morimura K; Wanibuchi H; Salim EI; Kinoshita A; Kaneko M; Vozianov A; Fukushima S
    Int J Cancer; 2000 Jun; 86(6):790-8. PubMed ID: 10842192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-KIT positive schistosomal urinary bladder carcinoma are frequent but lack KIT gene mutations.
    Shams TM; Metawea M; Salim EI
    Asian Pac J Cancer Prev; 2013; 14(1):15-20. PubMed ID: 23534715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of inducible nitric oxide synthase and accumulation of 8-OHdG in nasopharyngeal carcinoma.
    Segawa Y; Oda Y; Yamamoto H; Uryu H; Shiratsuchi H; Hirakawa N; Tomita K; Yamamoto T; Oda S; Yamada T; Komune S; Tsuneyoshi M
    Histopathology; 2008 Jan; 52(2):213-23. PubMed ID: 18184270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 and c-erbB-2 expression in schistosomal urinary bladder carcinomas and schistosomal cystitis with premalignant lesions.
    Kamel D; Soini Y; Nuorva K; Khalifa A; Mangoud A; Vähäkangas K; Pääkkö P
    Virchows Arch; 1994; 424(4):349-55. PubMed ID: 7911381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papilloma virus and p53 expression in bladder cancer in Egypt: relationship to schistosomiasis and clinicopathologic factors.
    Helal Tel A; Fadel MT; El-Sayed NK
    Pathol Oncol Res; 2006; 12(3):173-8. PubMed ID: 16998598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.
    Youssef R; Kapur P; Kabbani W; Shariat SF; Mosbah A; Abol-Enein H; Ghoniem M; Lotan Y
    BJU Int; 2011 Jul; 108(1):31-7. PubMed ID: 21105986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.
    Chaudhary KS; Lu QL; Abel PD; Khandan-Nia N; Shoma AM; el Baz M; Stamp GW; Lalani EN
    Br J Urol; 1997 Jan; 79(1):78-84. PubMed ID: 9043502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-like metabolites and DNA-adducts in urogenital schistosomiasis-associated bladder cancer.
    Gouveia MJ; Santos J; Brindley PJ; Rinaldi G; Lopes C; Santos LL; da Costa JM; Vale N
    Cancer Lett; 2015 Apr; 359(2):226-32. PubMed ID: 25615421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
    Makboul R; Refaiy A; Abdelkawi IF; Hameed DA; Elderwy AA; Shalaby MM; Merseburger AS; Hussein MR
    Pathol Res Pract; 2016 May; 212(5):385-92. PubMed ID: 26916953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the urinary bladder associated with schistosomiasis in Egypt: the possible causal relationship.
    Tawfik HN
    Princess Takamatsu Symp; 1987; 18():197-209. PubMed ID: 3147281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer.
    El-Sheikh SS; Madaan S; Alhasso A; Abel P; Stamp G; Lalani EN
    BJU Int; 2001 Dec; 88(9):921-7. PubMed ID: 11851614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients.
    Obtulowicz T; Swoboda M; Speina E; Gackowski D; Rozalski R; Siomek A; Janik J; Janowska B; Ciesla JM; Jawien A; Banaszkiewicz Z; Guz J; Dziaman T; Szpila A; Olinski R; Tudek B
    Mutagenesis; 2010 Sep; 25(5):463-71. PubMed ID: 20534734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.
    Bartoletti R; Cai T; Nesi G; Sardi I; Rizzo M
    Oncol Rep; 2005 Jul; 14(1):251-5. PubMed ID: 15944797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/neu, and proliferation (MIB-1).
    Badr KM; Nolen JD; Derose PB; Cohen C
    Hum Pathol; 2004 Feb; 35(2):184-9. PubMed ID: 14991535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.